InflaRx N.V.

NASDAQ:IFRX

Biotechnology

Healthcare
$1.09 -0.82%

-$0.02 today

Market cap
$160.63M
Beta
2.44
P/E (TTM)
-2.7
EPS (TTM)
-$0.59
52W Low $0.74High $2.95

Volume 0.66M

Average 1.80M

Price history

InflaRx N.V. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-13.49%

Period high

$2.74

Period low

$0.83

Latest

$1.09

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
6-KNov 6, 2026Nov 6, 2026
6-KNov 3, 2026Nov 3, 2026
6-KNov 3, 2026Nov 3, 2026
6-KOct 22, 2026Oct 22, 2026
SC 13GAug 17, 2026Aug 17, 2026
424B5Aug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
EFFECTAug 12, 2026Aug 13, 2026
F-3Aug 6, 2026Aug 6, 2026
SC 13GAug 6, 2026Aug 6, 2026
S-8Aug 6, 2026Aug 6, 2026
6-KAug 6, 2026Aug 6, 2026
6-KJun 30, 2026Jun 30, 2026

Competitors

Who does InflaRx N.V. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IFRX's filings, answered from its disclosures.

What is the latest IFRX filing?

The latest filing shown is 6-K dated Nov 6, 2026.

How many recent filings does IFRX have?

Intrinsic Alpha currently shows 20 recent filings for IFRX.